| 71335-2696-1 |
71335-2696 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250924 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021777 |
Bryant Ranch Prepack |
CYCLOBENZAPRINE HYDROCHLORIDE |
30 mg/1 |
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2696-1) |
| 71335-2696-2 |
71335-2696 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
CAPSULE, EXTENDED RELEASE |
ORAL |
20250924 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021777 |
Bryant Ranch Prepack |
CYCLOBENZAPRINE HYDROCHLORIDE |
30 mg/1 |
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2696-2) |
| 72189-389-60 |
72189-389 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine HCL ER |
Cyclobenzaprine HCL ER |
CAPSULE, EXTENDED RELEASE |
ORAL |
20221109 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021777 |
Direct_Rx |
CYCLOBENZAPRINE HYDROCHLORIDE |
15 mg/1 |
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72189-389-60) |
| 0115-1437-13 |
0115-1437 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
CAPSULE, EXTENDED RELEASE |
ORAL |
20190301 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021777 |
Amneal Pharmaceuticals of New York LLC |
CYCLOBENZAPRINE HYDROCHLORIDE |
30 mg/1 |
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13) |
| 0093-1921-06 |
0093-1921 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
CAPSULE, EXTENDED RELEASE |
ORAL |
20190304 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021777 |
Teva Pharmaceuticals USA, Inc. |
CYCLOBENZAPRINE HYDROCHLORIDE |
30 mg/1 |
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06) |